phosphotyrosine has been researched along with Diffuse Large B-Cell Lymphoma in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bahlis, N; Mansoor, A; Stewart, DA | 1 |
| Bachi, A; Carniti, C; Colombo, E; Donella-Deana, A; Galietta, A; Gambacorti-Passerini, C; Gunby, RH; Huang, CJ; Marin, O; Perrotti, D; Piazza, RG; Pulford, K; Puttini, M; Redaelli, S; Ruchatz, H; Stano, P; Tartari, CJ; Tucker, PW; Villa, A | 1 |
| Charron, D; Drénou, B; Garban, F; Jacob, MC; Lord, J; Mooney, N; Plumas, J; Sotto, JJ; Truman, JP | 1 |
| Biddolph, S; Delsol, G; Jones, M; Mason, DY; Pulford, K; Roncador, G | 1 |
| Arnold, MD; Frist, AY; Pulford, K; Seth, P; Turturro, F | 1 |
5 other study(ies) available for phosphotyrosine and Diffuse Large B-Cell Lymphoma
| Article | Year |
|---|---|
pY-STAT3 and p53 expression predict outcome for poor prognosis diffuse large B-cell lymphoma treated with high dose chemotherapy and autologous stem cell transplantation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Melphalan; Middle Aged; Neoplasm Proteins; Phosphorylation; Phosphotyrosine; Podophyllotoxin; Prednisone; Prognosis; Prospective Studies; Protein Processing, Post-Translational; STAT3 Transcription Factor; Transplantation, Autologous; Tumor Suppressor Protein p53; Vincristine | 2009 |
NPM/ALK binds and phosphorylates the RNA/DNA-binding protein PSF in anaplastic large-cell lymphoma.
Topics: Animals; Apoptosis; Cell Line; DNA-Binding Proteins; Humans; Lymphoma, Large B-Cell, Diffuse; Mice; Phosphorylation; Phosphotyrosine; Protein Binding; Protein-Tyrosine Kinases; PTB-Associated Splicing Factor; RNA; RNA-Binding Proteins; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Transcription, Genetic | 2007 |
Signal transduction via human leucocyte antigen class II molecules distinguishes between cord blood, normal, and malignant adult B lymphocytes.
Topics: Adult; Age Factors; Antigen Presentation; B-Lymphocytes; Cell Aggregation; Cell Differentiation; Cell Division; Enzyme Activation; Fetal Blood; HLA-DR Antigens; Humans; Infant, Newborn; Isoenzymes; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphocyte Activation; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Neoplastic Stem Cells; Phosphorylation; Phosphotyrosine; Protein Kinase C; Protein Kinase C beta; Protein Kinase C-alpha; Protein Processing, Post-Translational; Signal Transduction | 1998 |
Immunohistochemical screening for oncogenic tyrosine kinase activation.
Topics: Antibodies, Monoclonal; Burkitt Lymphoma; Chromosomes, Human, Pair 2; Chromosomes, Human, Pair 5; Enzyme Activation; Humans; Immunoenzyme Techniques; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Neoplasm Proteins; Oncogenes; Phosphotyrosine; Protein-Tyrosine Kinases; Translocation, Genetic; Tumor Cells, Cultured | 1999 |
Biochemical differences between SUDHL-1 and KARPAS 299 cells derived from t(2;5)-positive anaplastic large cell lymphoma are responsible for the different sensitivity to the antiproliferative effect of p27(Kip1).
Topics: Adenoviridae; Apoptosis; Cell Cycle; Cell Cycle Proteins; Chromosomes, Human, Pair 2; Chromosomes, Human, Pair 5; Culture Media, Serum-Free; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p27; Genetic Vectors; Humans; Isoenzymes; Lymphoma, Large B-Cell, Diffuse; Neoplasm Proteins; Phospholipase C gamma; Phosphoproteins; Phosphoric Monoester Hydrolases; Phosphorylation; Phosphotyrosine; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Recombinant Fusion Proteins; S Phase; Transfection; Translocation, Genetic; Tumor Cells, Cultured; Tumor Suppressor Proteins; Type C Phospholipases | 2001 |